Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.17 -0.33 (-0.21%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Wall Street sees these 2023 losers as 2024 opportunities
Analysts are pointing at undervalued, oversold companies like these three S&P 500 laggards as potential investment opportunities heading into 2024. 
Via MarketBeat
Topics Stocks
Exposures US Equities
3 Dividend Stocks That Could Pay for Your Holiday Shopping
Celebrate the holiday season without any worry and pay for your holiday shopping with these three dividend stocks. 
Via InvestorPlace
3 Dividend Stocks to Buy for Consistent Income
Smart investing in dividend stocks for income can help ensure a steady cash flow and achieve long-term financial security. 
Via InvestorPlace
2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague
Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever
Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why the dividend investor may take a look at NYSE:JNJ.
Is JOHNSON & JOHNSON (NYSE:JNJ) a Good Fit for Dividend Investing? 
Via Chartmill
Looking Into Johnson & Johnson's Recent Short Interest
Via Benzinga
Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Clorox Company’s (NYSE: CLX) recent quarter was "ok." He added, "I think that the hack is behind them. 
Via Benzinga
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade
Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream. 
Via The Motley Fool
Long-Term Winners: Ray Dalio’s Top 3 Stock Recommendations for a Prosperous Future
Supercharge your investment portfolio with these three Ray Dalio stock picks offering incredible upside ahead. 
Via InvestorPlace
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) raised their voices by calling out sick or walking out... 
Via Benzinga
MarketBeat Week in Review – 10/30 - 11/3
Equities rallied as the theme of bad news is good news is back; investors now wait for the latest read on inflation and its impact on holiday spending 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
Dividend stocks can cushion your portfolio in times of market trouble. 
Via The Motley Fool
The 3 Best Forever Stocks to Buy in November
While the idea of acquiring “forever stocks” is risky due to the timeframe, these companies benefit from permanent relevance. 
Via InvestorPlace
3 Healthcare Stocks to Buy Hand Over Fist in November
Get these stocks while they're cheap. 
Via The Motley Fool
Amgen Wins Big With FDA, Analyst Sees Soaring Potential
The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson's (NYSE: JNJ) psoriasis treatment, Stelara, for multiple inflammatory diseases sent 
Via Benzinga
Exposures Product Safety
EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'
A new ETF offers investors exposure to companies with long streaks of raising their dividends. 
Via Benzinga
Topics ETFs
3 Dividend Kings Whose Growth Streaks Could Break Before 2030
Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago. 
Via The Motley Fool
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
Via Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END 
Via FinancialNewsMedia
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?
Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own? 
Via The Motley Fool
Investor patience tested as pharmaceutical stocks take a tumble
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector 
Via MarketBeat
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have  
Via Benzinga
J&J stock down as business unit mulls talc-related bankruptcy
Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements. 
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks
The Oracle of Omaha likes big stocks. 
Via The Motley Fool
Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks
The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses. 
Via The Motley Fool
Meta's Plans, Cyberattacks, and the EV Race
And we've got a look at two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
These elite companies make exceptional foundational investments for any portfolio. 
Via The Motley Fool
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
A few hundred dollars invested today could go a long way over time. 
Via The Motley Fool
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
Ozempic, Novo Nordisk’s (NYSE: NVO) diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.